Journal article

An individualised risk-adapted protocol of pre-and post transplant zoledronic acid reduces bone loss after allogeneic stem cell transplantation: results of a phase II prospective trial

A Grigg, B Butcher, B Khodr, A Bajel, M Hertzberg, S Patil, AB D'Souza, P Ganly, P Ebeling, E Wong

Bone Marrow Transplantation | NATURE PUBLISHING GROUP | Published : 2017